Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2011
This study aims to test the hypothesis that the accelerated infusion of infliximab is not inferior to the conventional 2 hour infusion with respect to the frequency of infusion reaction.
Epistemonikos ID: 5562283db06113fa4c2256bfd4982e05ef38be41
First added on: Mar 23, 2022